ARMO Shares Outstanding History
Below is a table of the ARMO shares outstanding history going back to 1/26/2018:

Date ARMO Shares Outstanding

Also see: ARMO Market Cap History
ARMO Historical Shares Outstanding:
+24.85% CAGR
ARMO Historical Shares Outstanding: +24.85% CAGR

Mouse over chart for data details
1/26/2018 ...5/10/2018
ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors. Co.'s lead product candidate includes AM0010, a drug that is in Phase III randomized pivotal clinical trial for the treatment of pancreatic ductal adenocarcinoma and chemotherapy. Co. is also developing AM0010 with anti-PD-1 immune checkpoint inhibitor that has completed Phase I/Ib clinical trial for the treatment of non-small cell lung cancer, as well as that is in Phase I/Ib clinical trial for the treatment of renal cell carcinoma, and melanoma and other solid tumors. We show 3 historical shares outstanding datapoints in our coverage of ARMO's shares outstanding history.

Understanding the changing numbers of ARMO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ARMO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ARMO by allowing them to research ARMO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ARMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ARMO BioSciences (ARMO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ARNA Shares Outstanding History
ARPO Shares Outstanding History
ARQL Shares Outstanding History
ARQT Shares Outstanding History
ARTL Shares Outstanding History
ARVN Shares Outstanding History
ARWR Shares Outstanding History
ASMB Shares Outstanding History
ASNS Shares Outstanding History
ASRT Shares Outstanding History
More Healthcare companies »


ARMO Shares Outstanding History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.